Dillard's - DDS Stock Forecast, Price & News

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Dillard's in the last twelve months. There are currently 2 sell ratings and 1 hold rating for the stock. The consensus among Wall Street equities research analysts is that investors should "sell" DDS shares.
View DDS analyst ratings or view top-rated stocks.

3 Wall Street research analysts have issued 12-month target prices for Dillard's' shares. Their DDS share price forecasts range from $150.00 to $380.00. On average, they anticipate the company's stock price to reach $256.25 in the next twelve months. This suggests that the stock has a possible downside of 14.8%.
View analysts price targets for DDS or view top-rated stocks among Wall Street analysts.

Dillard's' stock was trading at $323.20 at the beginning of 2023. Since then, DDS shares have decreased by 7.0% and is now trading at $300.64.
View the best growth stocks for 2023 here.

Dillard's saw a decrease in short interest in February. As of February 28th, there was short interest totaling 1,360,000 shares, a decrease of 5.6% from the February 13th total of 1,440,000 shares. Based on an average daily volume of 132,400 shares, the days-to-cover ratio is presently 10.3 days. Approximately 15.2% of the company's stock are short sold.
View Dillard's' Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 11th 2023.
View our DDS earnings forecast.

Dillard's, Inc. (NYSE:DDS) posted its earnings results on Thursday, November, 11th. The company reported $9.81 earnings per share for the quarter, topping analysts' consensus estimates of $5.52 by $4.29. The business earned $1.48 billion during the quarter, compared to analysts' expectations of $1.27 billion. Dillard's had a trailing twelve-month return on equity of 55.47% and a net margin of 12.98%.

Dillard's announced a quarterly dividend on Thursday, February 23rd. Stockholders of record on Friday, March 31st will be given a dividend of $0.20 per share on Monday, May 1st. This represents a $0.80 dividend on an annualized basis and a dividend yield of 0.27%. The ex-dividend date of this dividend is Thursday, March 30th.
Read our dividend analysis for DDS.

ETFs with the largest weight of Dillard's (NYSE:DDS) stock in their portfolio include Alpha Architect U.S. Quantitative Value ETF (QVAL), Cambria Value and Momentum ETF (VAMO), Alpha Architect U.S. Quantitative Momentum ETF (QMOM), Cambria Shareholder Yield ETF (SYLD), SPDR S&P Retail ETF (XRT), Inspire Fidelis Multi Factor ETF (FDLS), Direxion Daily Retail Bull 3X Shares (RETL) and Hartford Multifactor Small Cap ETF (ROSC).

Dillard's (NYSE:DDS) pays an annual dividend of $0.80 per share and currently has a dividend yield of 0.27%. The dividend payout ratio is 1.57%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, DDS will have a dividend payout ratio of 2.51% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for DDS.

2,306 employees have rated Dillard's Chief Executive Officer Bill Dillard II on Glassdoor.com. Bill Dillard II has an approval rating of 46% among the company's employees. This puts Bill Dillard II in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Dillard's investors own include Intel (INTC), Walt Disney (DIS), Micron Technology (MU), Cisco Systems (CSCO), CVS Health (CVS), General Electric (GE), Abbott Laboratories (ABT), Advanced Micro Devices (AMD), Gilead Sciences (GILD) and Hawkins (HWKN).

Dillard's trades on the New York Stock Exchange (NYSE) under the ticker symbol "DDS."

Dillard's' stock is owned by a variety of institutional and retail investors. Top institutional investors include Newport Trust Co (30.15%), Dimensional Fund Advisors LP (5.63%), Wedge Capital Management L L P NC (0.65%), Morgan Stanley (0.53%), Alyeska Investment Group L.P. (0.51%) and Millennium Management LLC (0.43%). Insiders that own company stock include Chris B Johnson, Dean L Worley, Drue Matheny, J C Watts Jr, James I Freeman, James I Freeman, Mike Litchford, Reynie Rutledge, Tom W Bolin, Tony J Bolte and Warren A Stephens.
View institutional ownership trends.

Shares of DDS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of DDS stock can currently be purchased for approximately $300.64.

Dillard's (NYSE:DDS) has a market capitalization of $5.15 billion and generates $6.87 billion in revenue each year. The company earns $891.60 million in net income (profit) each year or $50.83 on an earnings per share basis.

The company employs 30,500 workers across the globe.

Dillard's' mailing address is 1600 CANTRELL ROAD, LITTLE ROCK AR, 72201. The official website for the company is www.dillards.com. The company can be reached via phone at (501) 376-5200, via email at julie.bull@dillards.com, or via fax at 501-376-5917.